Ospemifene
- Generic Name
- Ospemifene
- Brand Names
- Osphena, Senshio
- Drug Type
- Small Molecule
- Chemical Formula
- C24H23ClO2
- CAS Number
- 128607-22-7
- Unique Ingredient Identifier
- B0P231ILBK
Overview
Ospemifene is a new selective non-hormonal estrogen receptor modulator (SERM) that is used for the treatment of moderate to severe dyspareunia, a symptom of vulvar and vaginal atrophy, due to menopause. FDA approved on February 26, 2013.
Background
Ospemifene is a new selective non-hormonal estrogen receptor modulator (SERM) that is used for the treatment of moderate to severe dyspareunia, a symptom of vulvar and vaginal atrophy, due to menopause. FDA approved on February 26, 2013.
Indication
Ospemifene is indicated for the treatment of moderate to severe dyspareunia and vaginal dryness associated with menopause.
Associated Conditions
- Moderate Dyspareunia
- Moderate Vaginal dryness
- Severe Dyspareunia
- Severe Vaginal dryness
Clinical Trials
FDA Approved Products
Osphena
Manufacturer:Duchesnay USA, Inc.
Route:ORAL
Strength:60 mg in 1 1
Approved: 2023/04/21
NDC:55494-580
Osphena
Manufacturer:Shionogi Inc.
Route:ORAL
Strength:60 mg in 1 1
Approved: 2023/03/16
NDC:59630-580
Singapore Approved Products
No Singapore products found for this drug
Drug Development Updates
Stay informed with timely notifications on clinical trials and research advancements.
© Copyright 2025. All Rights Reserved by MedPath